Non-prescription market as a share of total pharmaceutical market
EUR million. Excluding hospital sales. At consumer price level unless otherwise stated.
Austria
Belgium
Bulgaria
Croatia (WP)
Denmark
Estonia
Finland (WP)
Germany
Greece (MP)
Hungary (MSP)
Ireland (MSP)
Italy
Latvia (WP)
Lithuania (MSP)
Netherlands
Poland (MSP)
Portugal
Romania (MSP to 2013, CP 2013-2016)
Russia
Serbia
Slovakia (MSP)
Slovenia (WP for 2013-2015)
Spain
Sweden
Switzerland (WP)
Turkey (MSP)
Ukraine
United Kingdom (MSP)
Argentina (MSP)
Brazil (WP)
Canada (MSP)
Chile
China (MSP)
Colombia (MSP)
Israel
Japan (MSP)
Mexico
New Zealand
Philippines (MSP)
Venezuela (MSP)
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
13.7
14.4
15.2
15.4
16
16.3
16